Xempa 10 Tablet belongs to the category of medicines called 'anti-diabetic' primarily used for the management and treatment of type 2 diabetes. Type 2 diabetes is a condition that occurs when there is either less insulin or available insulin is not properly utilized by our body cells for lowering raised blood glucose. It is the most common type of diabetes, accounting for around 90% of total diabetes cases found commonly in middle-aged people. So it is also called adult-onset diabetes or non-insulin-dependent diabetes mellitus (NIDDM). Xempa 10 Tablet contains 'Dapagliflozin' a protein found in kidney known as sodium-glucose cotransporters-2 (SGLT-2 inhibitor) that works by inhibiting the reabsorption of glucose in the body, resulting in an increase in glucose excretion through urine. The removal of excessive glucose helps to lower down the blood sugar level. Treatment of Type 2 Diabetes Mellitus Xempa 10 Tablet belongs to the anti-diabetic drug category, indicated in the treatment of type 2 diabetes or non-insulin-dependent diabetes (NIDDM). This medicine is primarily prescribed to persons whose blood sugar levels are high and not controlled by diet and exercise alone. Xempa 10 Tablet consists of “Dapagliflozin” a sodium-glucose cotransporter-2 (SGLT-2) inhibitor responsible for inhibiting SGLT-2 enzymes in the kidney. Thus, it prevents the reabsorption of glucose from the blood filtered through your kidney, thereby increasing the glucose excretion from your body when you urinate.